Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Bluejay Diagnostics (BJDX) Return on Sales (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed Return on Sales for 2 consecutive years, with 37.68% as the latest value for Q4 2023.

  • Quarterly Return on Sales fell 701.0% to 37.68% in Q4 2023 from the year-ago period, while the trailing twelve-month figure was 37.68% through Dec 2023, down 701.0% year-over-year, with the annual reading at 8171.93% for FY2025, 816240.0% up from the prior year.
  • Return on Sales hit 37.68% in Q4 2023 for Bluejay Diagnostics, up from 54.15% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 7.97% in Q2 2022 to a low of 54.15% in Q3 2023.